- Home
- / Immune Design
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Immune Design financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$2.2 M
FY, 2018
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|---|
| Revenue | 6.4M | 9.5M | 13.3M | 7.2M | 2.2M |
| Cost of goods sold | 638.0K | 774.0K | 481.0K | 84.0K | 1.4M |
| Gross profit | 5.8M | 8.7M | 12.8M | 7.1M | 761.0K |
| Gross profit margin, % | 90.1% | 91.9% | 96.4% | 98.8% | 34.7% |
| General and administrative expense | 12.9M | 15.1M | 21.9M | 16.3M | 15.4M |
| Operating expense total | 35.7M | 48.2M | 67.0M | 59.9M | 57.8M |
| EBIT | (29.9M) | (39.5M) | (54.2M) | (52.8M) | (57.0M) |
| EBIT margin, % | -464.4% | -415.2% | -408.9% | -734.0% | -2597.9% |
| Net Income | (34.2M) | (39.4M) | (53.5M) | (51.9M) | (54.8M) |